New test aims to Fine-Tune heart medication, reduce bleeding risk

NCT ID NCT06216821

Recruiting now Disease control Sponsor: Shenyang Northern Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing if a new risk score can help doctors decide the best time to reduce the intensity of blood-thinning therapy for patients who had a heart attack and received a stent. About 3,500 participants will be assigned to have their medication adjusted either after 1 month or 3 months based on their personal risk score. The goal is to find the safest balance between preventing future clots and avoiding serious bleeding complications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

General Hospital of Northern Theater Command
RECRUITING

Shenyang, Liaoning, 110016, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE CORONARY SYNDROME